Delivery Order SPE2DB20D2104-SPE2DB22FQ88T
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,339.87 Firm-Fixed-Price Delivery Order is for the supply of APO-VARENICLINE 0.5 MG TABLET 56S, a medication used to treat nicotine addiction. The award has an ultimate completion date of October 11, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- This federal contract award is for the delivery of APO-VARENICLINE 0.5 MG TABLET 56S, a prescription medication, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $5,565.16, was awarded on May 13, 2022, with a completion date of May 16, 2022. This is a delivery order contract with a firm fixed price pricing type. The contract does not have a set-aside designation, indicating open competition....
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $12,500.52, is for the delivery of APO-VARENICLINE 0.5 MG TABLET 56S, a pharmaceutical product, and has an ultimate completion date of September 23, 2021. The contract is a delivery order type, with a firm fixed price pricing structure. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a...
- This federal contract award, valued at $2,427.95, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of APO-VARENICLINE 1 MG TABLET 56S, a medication used in smoking cessation treatments. This is a firm fixed-price delivery order contract that has an ultimate completion date of December 3, 2021. The contract does not have a set-aside designation, indicating it...
- This federal contract award, valued at $16,146.92, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4554932510 - APO-VARENICLINE 1 MG TABLET 56S, a prescription medication. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC,...
- This federal contract award is for the delivery of 56 count tablets of the medication varenicline, with a ceiling value of $1,269.11. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical division, valued at $999,999,999 and running through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,555,125,269 units of the medication APO-VARENICLINE 0.5 MG TABLET 56S. The fixed-price delivery order, valued at $12,593.02, has an ultimate completion date of October 20, 2021. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract...
- This federal contract award is for the delivery of APO-VARENICLINE 0.5 MG TABLET 56S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $18,312.86 and was awarded on September 20, 2023, with an ultimate completion date of September 21, 2023. The contract is a delivery order and is priced as a firm fixed price. It is not...
- This federal contract award is for the delivery of VARENICLINE 1 MG TABLET 56S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $4,010.85, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and running through November 2026. This...
- This federal contract award for $2,073.75 was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a firm-fixed price delivery order for the supply of 56 tablets of 1 mg Varenicline, a medication used to treat nicotine addiction. The contract has an ultimate completion date of July 17, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB22FQ88TDelivery Order
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of APO-VARENICLINE 1 MG TABLET 56S, a prescription medication. The contract, valued at $1,592.51, was awarded on November 2, 2021, by the Defense Logistics Agency (DLA), a defense agency. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 and running through December 2025. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contract award does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 11/2/21 |